Cancer Medicines Value in Context: PhRMA Report May 2019 - A slide resource kit
PhRMA released its Cancer Medicines Value in Context slide deck. It is a rich cache of data and slides resources on the current cancer market. Click on image to download full deck of slide resources. The key take aways from the deck: We have made remarkable progress in the fight against the more than 200 diseases we call cancer and current research holds enormous promise to address the great unmet need. Too many cancer patients face financial burdens, and these comes from a
Top 20 Drugs of 2018 from Fierce Pharma
"Check out the list below, and you'll notice several major blockbusters benefiting from biosimilar delays. You'll also see some small-molecule meds that are about to fall hard to generic competition. Overall, the assortment of drugs spans specialty fields such as cancer and immunology, and mass-market indications such as diabetes." Fierce Pharma Click on either image to go to article...
